Sunday, May 9, 2021 |
Mostly Cloudy

Potential COVID-19 treatment will be manufactured in Baltimore

January 26, 2021
covid-19 vaccine stock photo ig: @hakannural

Already part of several collaborations for COVID-19 vaccine candidates, Gaithersburg-based Emergent BioSolutions announced Monday that it will manufacture a potential treatment for the coronavirus called lenzilumab.  The drug, which is being developed by California-based Humanigen, Inc., is currently being tested in a phase 3 trial on hospitalized COVID-19 patients. It aims to prevent and treat “cytokine storm,” a severe, sometimes deadly, immune system reaction that can be caused by COVID-19.

Article Source: Daily Record

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.